Eyal C. Attar, SVP, Chief Medical Officer at Aprea Therapeutics, Inc. (APRE), sold 36,000 shares at $1.73 ($62K) on 2022-02-28, disclosed to the SEC on 2022-03-01.
Open-market sale of $62k APRE by SVP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VOR | SELL | 2024-12-31 | $13K | — | Filing → |
| VOR | SELL | 2024-06-04 | $20K | — | Filing → |
| APRE | SELL | 2021-09-20 | $149K | — | Filing → |